MétaCan
Menu
Back to cohort
Record W2896212671 · doi:10.1093/jnci/djy132

Height and Body Mass Index as Modifiers of Breast Cancer Risk in <i>BRCA1</i>/<i>2</i> Mutation Carriers: A Mendelian Randomization Study

2018· article· en· W2896212671 on OpenAlexafffund
Frank Qian, Shengfeng Wang, Jonathan S. Mitchell, Lesley McGuffog, Daniel Barrowdale, Goska Leslie, Jan C. Oosterwijk, Wendy K. Chung, D. Gareth Evans, Christoph Engel, Karin Kast, Cora M. Aalfs, Muriel A. Adank, Julian Adlard, Bjarni A. Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L. Andrulis, Banu Arun, Margreet G.E.M. Ausems, Jacopo Azzollini, Emmanuelle Barouk-Simonet, Julian Barwell, Muriel Belotti, Javier Benı́tez, Andreas Berger, Åke Borg, Angela R. Bradbury, Joan Brunet, Saundra S. Buys, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Sandrine M. Caputo, Jocelyne Chiquette, Kathleen Claes, J. Margriet Collée, Fergus J. Couch, Isabelle Coupier, Mary B. Daly, Rosemarie Davidson, Orland Dı́ez, Susan M. Domchek, Alan Donaldson, Cecilia M. Dorfling, Rosalind A. Eeles, Lídia Feliubadaló, Lenka Foretová, Jeffrey M. Fowler, Eitan Friedman, Debra Frost, Patricia A. Ganz, Judy E. Garber, Vanesa García‐Barberán, Gord Glendon, Andrew K. Godwin, E. Gómez, Jacek Gronwald, Eric Hahnen, Ute Hamann, Alex Henderson, Carolyn B. Hendricks, John L. Hopper, Peter J. Hulick, Evgeny N. Imyanitov, Claudine Isaacs, Louise Izatt, Á. Izquierdo, Anna Jakubowska, Katarzyna Kaczmarek, Eunyoung Kang, Beth Y. Karlan, Carolien M. Kets, Sung-Won Kim, Zisun Kim, Ava Kwong, Yael Laitman, Christine Lasset, Min Hyuk Lee, Jong Won Lee, Jihyoun Lee, Jenny Lester, Fabienne Lesueur, Jennifer T. Loud, Jan Lubiński, Noura Mebirouk, Hanne Meijers‐Heijboer, Alfons Meindl, Austin Miller, Marco Montagna, Thea M. Mooij, Patrick J. Morrison, Emmanuelle Mouret‐Fourme, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Dieter Niederacher, Finn Cilius Nielsen, Robert L. Nussbaum, Kenneth Offit, Edith Oláh, Kai-Ren Ong, Laura Ottini, Sue K. Park, Paolo Peterlongo, Georg Pfeiler, Catherine M. Phelan, Bruce Poppe, Nisha Pradhan, Paolo Radice, Susan J. Ramus, Johanna Rantala, Mark E. Robson, Gustavo C. Rodriguez, Rita K. Schmutzler, Christina G. Selkirk, Payal D. Shah, Jacques Simard, Christian F. Singer, Johanna Sokolowska, Dominique Stoppa‐Lyonnet, Christian Sutter, Yen Y. Tan, R Teixeira, Soo‐Hwang Teo, Mary Beth Terry, Mads Thomassen, Marc Tischkowitz, Amanda Ewart Toland, Kathy Tucker, Nadine Tung, Christi J. van Asperen, Klaartje van Engelen, Elizabeth J. van Rensburg, Shan Wang‐Gohrke, Barbara Wappenschmidt, Jeffrey N. Weitzel, Drakoulis Yannoukakos, Mark H. Greene, Matti A. Rookus, Douglas F. Easton, Georgia Chenevix‐Trench, Antonis C. Antoniou, David E. Goldgar, Olufunmilayo I. Olopade, Timothy R. Rebbeck, Dezheng Huo

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2018
Typearticle
Languageen
FieldMedicine
TopicCancer Risks and Factors
Canadian institutionsMcGill UniversityUniversité LavalCentre hospitalier universitaire de QuébecHôpital du Saint-SacrementMount Sinai HospitalLunenfeld-Tanenbaum Research InstituteUniversity of Toronto
FundersJonsson Comprehensive Cancer CenterNational Center for Advancing Translational SciencesInstituto de Salud Carlos IIIMedical Research CouncilCancer Center, University of KansasUniversity of California, Los AngelesNational Institutes of HealthKerry Group Kuok FoundationCentro de Investigación Biomédica en Red de CáncerUniversitätsklinikum Kölnlékařská fakulta Univerzity KarlovyNewcastle upon Tyne Hospitals NHS Foundation TrustInstitut Català de la SalutInstitut Gustave-RoussyMinistero dello Sviluppo EconomicoRoyal Marsden NHS Foundation TrustSahlgrenska UniversitetssjukhusetFondazione Italiana per la Ricerca sul CancroArcadia FundUppsala UniversitetHospices Civils de LyonNational Health and Medical Research CouncilDeutsche KrebshilfePritzker School of MedicineMedizinische Universität WienUniversitair Medisch Centrum GroningenUniversity of Texas MD Anderson Cancer CenterMemorial Sloan-Kettering Cancer CenterIstituto Oncologico VenetoInstitut National Du CancerLeids Universitair Medisch CentrumDivision of Cancer Epidemiology and Genetics, National Cancer InstituteCentre National de la Recherche ScientifiqueFox Chase Cancer CenterKWF KankerbestrijdingCanadian Institutes of Health ResearchEuropean CommissionCedars-Sinai Medical CenterLietuvos Mokslo TarybaHáskóli ÍslandsLombardi Comprehensive Cancer Center, Georgetown UniversityLandspítali HáskólasjúkrahúsIsrael Cancer AssociationChildren's Hospital of PhiladelphiaUniversity of Hong KongHarvard T.H. Chan School of Public HealthHungarian Scientific Research FundHuntsman Cancer InstituteFonds Wetenschappelijk OnderzoekUniversity of PretoriaRadboud Universitair Medisch CentrumUniversität WienErasmus Medisch CentrumNederlandse Organisatie voor Wetenschappelijk OnderzoekGentofte HospitalUniversity of TorontoUniverzita Karlova v PrazeMcGill UniversityGeneralitat de CatalunyaSoonchunhyang UniversityNational Breast Cancer FoundationNational Cancer InstituteEuropean Regional Development FundPeking UniversitySeoul National UniversityMinistère du Développement Économique, de l’Innovation et de l’ExportationRigshospitaletUniversity of MelbourneRijksuniversiteit GroningenMaastricht Universitair Medisch CentrumMoffitt Cancer CenterOhio State UniversityUniversiteit LeidenMinisterstvo Školství, Mládeže a TělovýchovyLiga Portuguesa Contra o CancroHelsingin YliopistoHospital de Câncer de BarretosPomorski Uniwersytet Medyczny W SzczecinieVrije Universiteit AmsterdamSeoul National University Bundang HospitalMinistero della SaluteInstitut National de la Santé et de la Recherche MédicaleCancer AustraliaRadboud UniversiteitFundación Mutua MadrileñaUniversität UlmCancer Research UKAssociazione Italiana per la Ricerca sul CancroBeckman Research Institute, City of HopeWellcome TrustBreast Cancer Research FoundationUnicancerClalit Health ServicesDeutsches KrebsforschungszentrumJewish General HospitalNational Institute for Health and Care ResearchUniversity of KansasFreistaat SachsenKansas Bioscience AuthorityUniversity of ChicagoNorthShore University HealthSystemCancer Research InstituteUniversity Hospitals of Leicester NHS TrustNRG OncologyTel Aviv UniversityUniversiteit MaastrichtFundación CellexFisher Center for Alzheimer's Research FoundationSchool of MedicineQIMR Berghofer Medical Research InstituteNational Institute on Handicapped ResearchGeorgetown University
KeywordsMendelian randomizationBreast cancerBody mass indexOncologyMendelian inheritanceMutationMedicineIndex (typography)RandomizationInternal medicineCancerGeneticsBiologyClinical trialGeneGenotypeComputer scienceGenetic variants

Abstract

fetched live from OpenAlex

BACKGROUND: BRCA1/2 mutations confer high lifetime risk of breast cancer, although other factors may modify this risk. Whether height or body mass index (BMI) modifies breast cancer risk in BRCA1/2 mutation carriers remains unclear. METHODS: We used Mendelian randomization approaches to evaluate the association of height and BMI on breast cancer risk, using data from the Consortium of Investigators of Modifiers of BRCA1/2 with 14 676 BRCA1 and 7912 BRCA2 mutation carriers, including 11 451 cases of breast cancer. We created a height genetic score using 586 height-associated variants and a BMI genetic score using 93 BMI-associated variants. We examined both observed and genetically determined height and BMI with breast cancer risk using weighted Cox models. All statistical tests were two-sided. RESULTS: Observed height was positively associated with breast cancer risk (HR = 1.09 per 10 cm increase, 95% confidence interval [CI] = 1.0 to 1.17; P = 1.17). Height genetic score was positively associated with breast cancer, although this was not statistically significant (per 10 cm increase in genetically predicted height, HR = 1.04, 95% CI = 0.93 to 1.17; P = .47). Observed BMI was inversely associated with breast cancer risk (per 5 kg/m2 increase, HR = 0.94, 95% CI = 0.90 to 0.98; P = .007). BMI genetic score was also inversely associated with breast cancer risk (per 5 kg/m2 increase in genetically predicted BMI, HR = 0.87, 95% CI = 0.76 to 0.98; P = .02). BMI was primarily associated with premenopausal breast cancer. CONCLUSION: Height is associated with overall breast cancer and BMI is associated with premenopausal breast cancer in BRCA1/2 mutation carriers. Incorporating height and BMI, particularly genetic score, into risk assessment may improve cancer management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.026
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.078

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.026
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.331
Teacher spread0.310 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations74
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicCancer Risks and FactorsFrench-language works237,207